# Vibeke Backer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vibeke-backer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,697 |
| Field | Asthma and respiratory diseases |
| h-index | 65 |
| i10-index | 308 |
| Last Known Institution | University of Copenhagen |
| OpenAlex ID | https://openalex.org/A5091795166 |
| ORCID iD | 0000-0002-7806-7219 |
| Works | 662 |

## Researcher papers

- [Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction](https://scholariq.org/papers/sequence-variants-affecting-eosinophil-numbers-associate-with-asthma-and/)
- [Preoperative Staging of Lung Cancer with Combined PET–CT](https://scholariq.org/papers/preoperative-staging-of-lung-cancer-with-combined-pet-ct/)
- [Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD](https://scholariq.org/papers/adherence-to-inhaled-therapies-health-outcomes-and-costs-in-patients-with-asthma/)
- [Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma](https://scholariq.org/papers/efficacy-of-a-house-dust-mite-sublingual-allergen-immunotherapy-tablet-in-adults/)
- [EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management](https://scholariq.org/papers/euforea-expert-board-meeting-on-uncontrolled-severe-chronic-rhinosinusitis-with/)
- [Benralizumab for the Prevention of COPD Exacerbations](https://scholariq.org/papers/benralizumab-for-the-prevention-of-copd-exacerbations/)
- [A daily SMS reminder increases adherence to asthma treatment: A three-month follow-up study](https://scholariq.org/papers/a-daily-sms-reminder-increases-adherence-to-asthma-treatment-a-three-month/)
- [Eosinophilic and Noneosinophilic Asthma](https://scholariq.org/papers/eosinophilic-and-noneosinophilic-asthma/)
- [INTRAVENOUS MAGNESIUM IN ACUTE MYOCARDIAL INFARCTION](https://scholariq.org/papers/intravenous-magnesium-in-acute-myocardial-infarction/)
- [Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial](https://scholariq.org/papers/effective-treatment-of-house-dust-mite-induced-allergic-rhinitis-with-2-doses-of/)
- [Effect of Olfactory Training in <scp>COVID</scp> ‐19 Related Olfactory Dysfunction—A Placebo‐Controlled Trial](https://scholariq.org/papers/effect-of-olfactory-training-in-scp-covid-scp-19-related-olfactory-dysfunction-a/)

## Researcher topics

- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Respiratory and Cough-Related Research](https://scholariq.org/topics/respiratory-and-cough-related-research/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Delphi Technique in Research](https://scholariq.org/topics/delphi-technique-in-research/)

## Researcher university

- [University of Copenhagen](https://scholariq.org/institutions/university-of-copenhagen/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.